GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Glenmark launches Tavulus(r) for COPD treatment in Spain, becoming one of the first companies to launch a bioequivalent version of the dry powder inhaler
Glenmark Pharmaceuticals Q2 PAT seen up 18.4% YoY to Rs 269.5 cr: Prabhudas Lilladher
Net Sales are expected to decrease by 4.2 percent Y-o-Y (down 5.4 percent Q-o-Q) to Rs 2,786.7 crore, according to Prabhudas Lilladher. GLENMARK PHARMACEUTICALS LTD. - 532296 - Clarification On News Item
Clarification on news item appearing in "Media/Publication" GLENMARK PHARMACEUTICALS LTD. - 532296 - Clarification sought from Glenmark Pharmaceuticals Ltd
The Exchange has sought clarification from Glenmark Pharmaceuticals Ltd with respect to news article appearing on https://www.business-standard.com October 3, 2021, titled "Drug makers Glenmark, Aurobindo Pharma recall products in US market".The reply is awaited. Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Glenmark receives marketing approval for Ryaltris(r), an innovative combination nasal spray, in 13 countries across the EU and UK
Glenmark Pharmaceuticals sees potential of NONS to prevent Covid-19
The firm, which has tasted success with its oral antiviral drug favipiravir, is now betting on the NONS to drive revenues from its Covid-19 portfolio GLENMARK PHARMACEUTICALS LTD. - 532296 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Glenmark Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Glenmark Pharmaceuticals Ltd - 532296 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Proceedings and Scrutinizer''s Report of the 43rd Annual General Meeting (AGM) of Glenmark Pharmaceuticals Limited (''the Company'') held on September 24, 2021 Glenmark Pharmaceuticals Ltd - 532296 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings and Scrutinizer''s Report of the 43rd Annual General Meeting (AGM) of Glenmark Pharmaceuticals Limited (''the Company'') held on September 24, 2021
Glenmark Pharma gets USFDA nod for generic antibiotic cream
Glenmark Pharma said it has received approval from the US health regulator to market Clindamycin Phosphate Foam, an antibiotic used for treating bacterial infections, in the American market